Christopher Morabito Net Worth & Insider Trades
Christopher Morabito - Chief Medical Officer, Fulcrum Therapeutics, Inc
What is Christopher Morabito's Net Worth?
The current estimated net worth of Fulcrum Therapeutics, Inc's Chief Medical Officer, Christopher Morabito, is estimated to be about $4.72K . Christopher Morabito owns about 1,100 units of Fulcrum Therapeutics, Inc common stock. In the last year at Fulcrum Therapeutics, Inc, Christopher Morabito has sold an estimated value of $0 worth.
What is Christopher Morabito's Past Insider Trading?
Christopher Morabito's largest purchase order was 1,100 units , worth over $10.08K on June 29, 2021. In total, Christopher Morabito has made about 3 transactions over a year of their time at Fulcrum Therapeutics, Inc. Christopher Morabito usually trades in January, June and May, with the busiest year in 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Christopher Morabito
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Christopher Morabito's' Mailing Address?
- Mailing address is C/o Fulcrum Therapeutics, Inc. 26 Landsdowne Street Cambridge MA 02139 MA
What are Fulcrum Therapeutics, Inc's Past Insider Trades?
Fulcrum Therapeutics, Inc's most recent insider trade came on May 11, 2023 by Greg Tourangeau who sold 210 units worth $695.1 . In the last 4 years, insiders at Fulcrum Therapeutics, Inc have sold an estimated value of $7.48M and bought an estimated value of $52.6M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Robert J Gould, Interim President & CEO, Diego Cadavid, SVP Clinical Development, and Owen B Wallace, Chief Scientific Officer .
Fulcrum Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |